News for Gossamer Bio, Inc. (4GB.MU)

Published at

Mar 6, 2021 12:23 AM

by prnewswire.com

positive

positive

Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial

/PRNewswire/ -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio...

GOSS ARPO 4GB.MU 4GB.F 335.MU 335.F 335.BE

Read more →
Published at

Mar 5, 2021 2:00 PM

by benzinga.com

positive

positive

Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial

SAN FRANCISCO and CINCINNATI, March 05, 2021 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will ...

GOSS ARPO 4GB.MU 4GB.F 335.MU 335.F 335.BE

Read more →
Published at

Feb 27, 2021 8:35 AM

by seekingalpha.com

neutral

neutral

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript

Gossamer Bio, Inc. (NASDAQ:GOSS) Q4 2020 Earnings Conference Call February 25, 2021 08:30 A.M.

GOSS 4GB.MU 4GB.F

Read more →
Published at

Feb 25, 2021 1:33 PM

by marketscreener.com

positive

positive

Gossamer Bio : Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update

- Seralutinib and GB004 continue to progress through ongoing Phase 2 TORREY and SHIFT-UC clinical trials for Pulmonary Arterial Hypertension and Ulcerative Colitis , respectively - - Topline... | February 25, 2021

GOSS 4GB.MU 4GB.F

Read more →

News for Gossamer Bio, Inc. (4GB.MU)

Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial

Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical's Razuprotafib in I-SPY COVID Trial

Gossamer Bio, Inc. (GOSS) CEO Faheem Hasnain on Q4 2020 Results - Earnings Call Transcript

Gossamer Bio : Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update